e-ISSN: Pending
Negative / Null Result ReportOpen accessNeurosciences. Biological psychiatry. Neuropsychiatry

PET Study in a Patient with Spinocerebellar Degeneration before and after Long-Term Administration of Thyrotropin Releasing Hormone

H. Tanji; H. Nagasawa; T. Hayashi; H. Onodera; T. Fujiwara; M. Itoh; T. Ido; Y. Itoyama · 1996 · Behavioural Neurology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

The finding, in one line

CMRG1c was markedly decreased in the cerebellum and there was no significant difference before and after the treatment, i.

Abstract

We studied the chronic effect of thyrotropin releasing hormone (TRH) in a patient with spinocerebellar degeneration by measuring cerebral metabolic rate for glucose (CMRG1c) using 2-[18F]fluoro-2-deoxy-D-glucose (18FDG) and positron emission tomography (PET). A 56-year-old female, who had suffered from progressive ataxia for 2 years, was treated by intravenous administration of 2 mg TRH for 3 weeks, and CMRG1c of the brain was measured before and after treatment. CMRG1c was markedly decreased in the cerebellum and there was no significant difference before and after the treatment, i.e. mean CM

Abstract by H. Tanji; H. Nagasawa; T. Hayashi; H. Onodera; T. Fujiwara; M. Itoh; T. Ido; Y. Itoyama, Behavioural Neurology (1996) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.3233/ben-1996-93-409